Development and evaluation of endothelin-A receptor (radio)ligands for positron emission tomography

Journal of Medicinal Chemistry

Volumn 54, Issue 4, 2011, Pages 939-948

  Michel, Kristin ^a   Büther, Katrin ^a   Law, Marilyn P ^b,c   Wagner, Stefan ^a   Schober, Otmar ^a   Hermann, Sven ^b   Schäfers, Michael ^b,c   Riemann, Burkhard ^a   Höltke, Carsten ^a   Kopka, Klaus ^a,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Interdisciplinary Center of Clinical Research IZKF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 BENZO[1,3]DIOXOL 5 YL 4 [3 [1 (2 [2 [2-(2-FLUOROETHOXY)ETHOXY]ETHOXY}ETHYL) 1H [1,2,3]TRIAZOL 4 YLMETHOXY] 4,5 DIMETHOXYBENZYL} 5 HYDROXY 5 (4 METHOXYPHENYL) 5H FURAN 2 ONE; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CLEARANCE; CONTROLLED STUDY; DRUG SCREENING; FEMALE; HYDROPHILICITY; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY;

ANIMALS; BINDING, COMPETITIVE; CLICK CHEMISTRY; FLUORINE RADIOISOTOPES; FURANS; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RECEPTOR, ENDOTHELIN A; TISSUE DISTRIBUTION; TRIAZOLES;

EID: 79951819901     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101110w     Document Type: Article

References (60)

1. Henry, P. J. Endothelin receptor distribution and function in the airways Clin. Exp. Pharamacol. Physiol. 1999, 26, 162-167
2. Barton, M.; Yanagisawa, M. Endothelin: 20 years from discovery to therapy Can. J. Physiol. Pharmacol. 2006, 17, 485-492
3. Dhaun, N.; Goddard, J.; Webb, D. J. The endothelin system and its antagonism in chronic kidney disease J. Am. Soc. Nephrol. 2006, 17, 943-955
4. Giaid, A.; Yanagisawa, M.; Langleben, D.; Michel, R. P.; Levy, R.; Shennib, H.; Kimura, S.; Masaki, T.; Duguid, W. P.; Stewart, D. J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N. Engl. J. Med. 1993, 328, 1732-1739 (Pubitemid 23170122)
5. Pittman, Q. J. Endothelin, an emerging role in proinflammatory pathways in brain Am. J. Physiol.: Regul. Integr. Comp. Physiol. 2006, 290, R162-R163
6. B receptor function in pancreatitis-associated microcirculatory failure, inflammation, and parenchymal injury Am. J. Physiol.: Gastrointest. Liver Physiol. 2003, 285, G145-G153 (Pubitemid 36736398)
7. Saito, Y.; Nakao, K.; Mukoyama, M.; Imura, H. Increased plasma endothelin level in patients with essential hypertension N. Engl. J. Med. 1990, 322, 205 (Pubitemid 20036412)
8. Teerlink, J. R.; Loffler, B. M.; Hess, P.; Maire, J. P.; Clozel, M.; Clozel, J. P. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan) Circulation 1994, 90, 2510-2518 (Pubitemid 24354340)
9. Nelson, J.; Bagnato, A.; Battistini, B.; Nisen, P. The endothelin axis: emerging role in cancer Nat. Rev. Cancer 2003, 3, 110-116 (Pubitemid 37328878)
10. Bagnato, A.; Natali, P. G. Targeting endothelin axis in cancer Cancer Treat. Res. 2004, 119, 293-314
11. Bagnato, A.; Rosanò, L. The endothelin axis in cancer Int. J. Biochem. Cell Biol. 2008, 40, 1443-1451
12. Bagnato, A.; Spinella, F.; Rosanò, L. The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy Can. J. Physiol. Pharmacol. 2008, 86, 473-484
13. Asham, E.; Shankar, A.; Loizidou, M.; Fredericks, S.; Miller, K.; Boulos, P. B.; Burnstock, G.; Taylor, I. Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism Br. J. Cancer 2001, 85, 1759-1763 (Pubitemid 34081524)
14. Bagnato, A.; Salani, D.; Di Castro, V.; Wu-Wong, J. R.; Tecce, R.; Nicotra, M. R.; Venuti, A.; Natali, P. G. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth Cancer Res. 1999, 59, 720-727 (Pubitemid 29076073)
15. Nelson, J. B.; Chan-Tack, K.; Hedican, S. P.; Magnuson, S. R.; Opgenorth, T. J.; Bova, G. S.; Simons, J. W. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer Cancer Res. 1996, 56, 663-668 (Pubitemid 26059878)
16. Alanen, K.; Deng, D. X.; Chakrabarti, S. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma Histopathology 2000, 36, 161-167 (Pubitemid 30113979)
17. Wülfing, P.; Diallo, R.; Kersting, C.; Wülfing, C.; Poremba, C.; Rody, A.; Greb, R. R.; Boecker, W.; Kiesel, L. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up Clin. Cancer Res. 2003, 9, 4125-4131 (Pubitemid 37204029)
18. Rosano, L.; Varmi, M.; Salani, D.; Di Castro, V.; Spinella, F.; Natali, P. G.; Bagnato, A. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells Cancer Res. 2001, 61, 8340-8346 (Pubitemid 33091630)
19. Salani, D.; Di Castro, V.; Nicotra, M. R.; Rosano, L.; Tecce, R.; Venuti, A.; Natali, P. G.; Bagnato, A. Role of endothelin-1 in neovascularization of ovarian carcinoma Am. J. Pathol. 2000, 157, 1537-1547
20. Del Bufalo, D.; Di Castro, V.; Biroccio, A.; Varmi, M.; Salani, D.; Rosano, L.; Trisciuoglio, D.; Spinella, F.; Bagnato, A. Endothelin-1 protects ovarian carcinoma cells against paclitaxel induced apoptosis: requirement for Akt activation Mol. Pharmacol. 2002, 61, 524-532 (Pubitemid 34171918)
21. Eberl, L. P.; Egidy, G.; Pinet, F.; Juillerat-Jeanneret, L. Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway J. Cardiovasc. Pharmacol. 2000, 36, S354-356
22. Ali, H.; Dashwood, M.; Dawas, K.; Loizidou, M.; Savage, F.; Taylor, I. Endothelin receptor expression in colorectal cancer J. Cardiovasc. Pharmacol. 2000, 36, S69-71
23. Winn, M.; Boyd, S. A.; Hutchins, C. W.; Jae, H.-S.; Tasker, A. S.; Vongeldern, T. W.; Kester, J. A.; Sorensen, B. K. Preparation of Pyrrolidinecarboxylic Acid Derivatives and Analogs as Endothelin Antagonists. WO 9606095 A1 19960229, Feb 29, 1996; Abbott Laboratories, U.S.
24. Bagnato, A.; Cirilli, A.; Salani, D.; Simeone, P.; Muller, A.; Nicotra, M. R.; Natali, P. G.; Venuti, A. Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade Cancer Res. 2002, 62, 6381-6384 (Pubitemid 35364090)
25. Rosano, L.; Spinella, F.; Salani, D.; Di Castro, V.; Venuti, A.; Nicotra, M. R.; Natali, P. G.; Bagnato, A. Therapeutic targeting of the endothelin A receptor in human ovarian carcinoma Cancer Res. 2003, 63, 2447-2453 (Pubitemid 36605182)
26. Carducci, M. A.; Nelson, J. B.; Bowling, M. K.; Rogers, T.; Eisenberger, M. A.; Sinibaldi, V.; Donehower, R.; Leahy, T. L.; Carr, R. A.; Isaacson, J. D.; Janus, T. J.; Andre, A.; Hosmane, B. S.; Padley, R. J. Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics J. Clin. Oncol. 2002, 20, 2171-2180 (Pubitemid 34408809)
27. Carducci, M. A.; Padley, R. J.; Breul, J.; Vogelzang, N. J.; Zonnenberg, B. A.; Daliani, D. D.; Schulman, C. C.; Nabulsi, A. A.; Humerickhouse, R. A.; Weinberg, M. A.; Schmitt, J. L.; Nelson, J. B. Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial J. Clin. Oncol. 2003, 21, 679-689 (Pubitemid 46621903)
28. Mathews, W. B.; Zober, T. G.; Ravert, H. T.; Scheffel, U.; Hilton, J.; Sleep, D.; Dannals, R. F.; Szabo, Z. Synthesis and in vivo evaluation of a PET radioligand for imaging the endothelin-A receptor Nucl. Med. Biol. 2006, 33, 15-19 (Pubitemid 43184073)
29. Aleksic, S.; Szabo, Z.; Scheffel, U.; Ravert, H. T.; Mathews, W. B.; Kerenyi, L.; Rauseo, P. A.; Gibson, R. E.; Burns, H. D.; Dannals, R. F. In vivo labeling of endothelin receptors with [(11)C]L-753,037: studies in mice and a dog J. Nucl. Med. 2001, 42, 1274-1280 (Pubitemid 32717849)
30. 18F]-SB209670 and positron emission tomography (microPET) J. Cardiovasc. Pharmacol. 2004, 44, S34-S38 (Pubitemid 40039639)
31. Berryman, K. A.; Doherty, A. M.; Edmunds, J. J.; Patt, W. C.; Plummer, M. S.; Repine, J. T. Preparation of 2(5 H)-Furanones, 2(5 H)-Thiophenones, 2(5 H)-Pyrrolones and Benzodioxolyls as Endothelin Antagonists. WO 9505376 A1 19950223, Feb 23, 1995; Warner Lambert Co., U.S.
32. A) receptor-selective antagonists J. Med. Chem. 1995, 38, 1259-1263
33. Patt, W. C.; Edmunds, J. J.; Repine, J. T.; Berryman, K. A.; Reisdorph, B. R.; Lee, C.; Plummer, M. S.; Shahripour, A.; Haleen, S. J.; Keiser, J. A.; Flynn, M. A.; Welch, K. M.; Reynolds, E. E.; Rubin, R.; Tobias, B.; Hallak, H.; Doherty, A. M. J. Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonists J. Med. Chem. 1997, 40, 1063-1074 (Pubitemid 27149260)
34. Höltke, C.; von Wallbrunn, A.; Kopka, K.; Schober, O.; Heindel, W.; Schäfers, M.; Bremer, C. A fluorescent photoprobe for the imaging of endothelin receptors Bioconjugate Chem. 2007, 18, 685-694 (Pubitemid 47010787)
35. Höltke, C.; Law, M. P.; Wagner, S.; Kopka, K.; Faust, A.; Breyholz, H. J.; Schober, O.; Bremer, C.; Riemann, B.; Schäfers, M. PET-compatible endothelin receptor radioligands: synthesis and first in vitro and in vivo studies Bioorg. Med. Chem. 2009, 17, 7197-7208
36. B-deficient mice Exp. Biol. Med. 2006, 231, 741-745 (Pubitemid 43845520)
37. Hamidi, M.; Azadi, A.; Rafiei, P. Pharmacokinetic consequences of pegylation Drug Delivery 2006, 13, 399-409 (Pubitemid 44470219)
38. Harris, J. M.; Chess, R. B. Effect of pegylation on pharmaceuticals Nat. Rev. Drug Discovery 2003, 2, 214-221 (Pubitemid 37361666)
39. Greenwald, R. B.; Choe, Y. H.; McGuire, J.; Conover, C. D. Effective drug delivery by PEGylated drug conjugates Adv. Drug Delivery Rev. 2003, 55, 217-250 (Pubitemid 36135917)
40. Kolb, H. C.; Sharpless, K. B. The growing impact of click chemistry on drug discovery Drug Discovery Today 2003, 8, 1128-1137 (Pubitemid 37547919)
41. Manetsch, R.; Krasinnski, A.; Radic, Z.; Raushel, J.; Taylor, P.; Sharpless, K. B.; Kolb, H. C. In situ click chemistry: enzyme inhibitors made to their own specifications J. Am. Chem. Soc. 2004, 126, 12809-12818 (Pubitemid 39372310)
42. Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Click-chemie: diverse chemische Funktionalität mit einer handvoll guter reaktionen Angew. Chem. 2001, 113, 2056-2075; Click chemistry: diverse chemical function from a few good reactions Angew. Chem., Int. Ed. 2001, 40, 2004 - 2021
43. Breyholz, H. J.; Wagner, S.; Faust, A.; Riemann, B.; Höltke, C.; Hermann, S.; Schober, O.; Schäfers, M.; Kopka, K. Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging ChemMedChem 2010, 5, 777-789
44. I catalyzed 1,3-dipolar cycloaddition Tetrahedron Lett. 2006, 47, 6681-6684 (Pubitemid 44176106)
45. 18F]fluoroethylazide for positron emission tomography Bioconjugate Chem. 2007, 18, 989-993 (Pubitemid 47010823)
46. 3 expression Bioconjugate Chem. 2007, 18, 1987-1994 (Pubitemid 350220000)
47. 18F-labeled neurotensin(8-13) via copper-mediated 1,3-dipolar [3+2]cycloaddition reaction Lett. Drug Des. Discovery 2007, 4, 279-285 (Pubitemid 46708892)
48. 18F-labeled folic acid derivative Bioconjugate Chem. 2008, 19, 2462-2470
49. 18F]-fluorobenzene for PET Bioconjugate Chem. 2009, 20, 817-823
50. 18F-glycopeptides as effective imaging probes for positron emission tomography Angew. Chem., Int. Ed. 2010, 49, 976 - 979
51. 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements J. Nucl. Med. 2006, 47, 520-527 (Pubitemid 46768495)
52. Ramenda, T.; Kniess, T.; Bergmann, R.; Steinbach, J.; Wuest, F. Radiolabelling of proteins with fluorine-18 via click chemistry Chem. Commun. 2009, 48, 7521-7523
53. 18F labeling of bioactive peptides J. Labelled Compd. Radiopharm. 2008, 51, 444-452
54. Zhu, L.; Liu, J. Fluorine-Containing Tetrabenazine Derivative as Vesicular Monoamine Transporter-Targeted Agent and Its Preparation Method. CN 101537193, A 20090923, Sept 23, 2009; Beijing Normal University, P. R. China.
55. Schrigten, D. Ph.D. Thesis, University of Münster, Münster, Germany. Unpublished results.
56. 18F]FPyKYNE, two new fluoropyridine-based reagents for the fluorine-18 labeling of macromolecules using click chemistry J. Labelled Compd. Radiopharm. 2009, 52 (S1) S184
57. Cheng, Y.; Prusoff, W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 1973, 22, 3099-3108
58. A receptor radioligands Bioorg. Med. Chem. 2006, 14, 1910-1917 (Pubitemid 43199522)
59. Prante, O.; Hocke, C.; Löber, S.; Hübner, H.; Gmeiner, P.; Kuwert, T. Tissue distribution of radioiodinated FAUC113: assessment of a pyrazolo(1,5- a)pyridine based dopamine D4 receptor radioligand candidate Nuklearmedizin 2006, 45, 41-44
60. Schäfers, K. P.; Reader, A. J.; Kriens, M.; Knoess, C.; Schober, O.; Schäfers, M. Performance evaluation of the 32-module quadHIDAC small-animal PET scanner J. Nucl. Med. 2005, 46, 996-1004 (Pubitemid 43733515)